Literature DB >> 12169122

Allergic otitis externa.

S Sood1, D R Strachan, A Tsikoudas, G I Stables.   

Abstract

Chronic otitis externa is a common condition, which is usually successfully treated by topical medications and aural toilet. In cases that persist despite conventional treatment, a diagnosis of allergic otitis externa should be considered. Sensitization to otic medications (secondary contact otitis) is not uncommon. Topical aminoglycosides are the most common sensitizers although many components of topical preparations can cause sensitization. Patients who may have developed allergic otitis externa should undergo patch testing. Otolaryngologists should consider using topical antibiotics with a low allergenic potential and avoiding neomycin when treating patients with otitis externa. Primary contact otitis may occur to metals used in earrings and also to hearing aid moulds. Treatment of both primary and secondary contact otitis consists of identifying the allergen, avoiding further contact and use of simple preparations avoiding common sensitizers.

Entities:  

Mesh:

Year:  2002        PMID: 12169122     DOI: 10.1046/j.1365-2273.2002.00584.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  7 in total

1.  [Pruritus, erythema and others. Dermatology of the ear].

Authors:  E Weisshaar; U Kallen; N Klintworth; J Zenk
Journal:  HNO       Date:  2011-03       Impact factor: 1.284

2.  Assessment of side effects after serial intralesional steroid injections for idiopathic subglottic stenosis.

Authors:  Ozlem Onerci Celebi; Sungjin A Song; Alena Santeerapharp; Kanittha Choksawad; Ramon A Franco
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-18       Impact factor: 2.503

Review 3.  Otitis Externa.

Authors:  Susanne Wiegand; Reinhard Berner; Antonius Schneider; Ellen Lundershausen; Andreas Dietz
Journal:  Dtsch Arztebl Int       Date:  2019-03-29       Impact factor: 5.594

4.  [Topical immunomodulation. A milestone for the treatment of therapy-resistant noninfectious chronic external otitis?].

Authors:  P P Caffier; W Harth; B Mayelzadeh; H Haupt; H Scherer; B Sedlmaier
Journal:  HNO       Date:  2008-05       Impact factor: 1.284

Review 5.  Safety of intrathecal route: focus to methylprednisolone acetate (Depo-Medrol) use.

Authors:  Joël Schlatter; David Nguyen; Michèle Zamy; Sofiane Kabiche; Jean-Eudes Fontan; Salvatore Cisternino
Journal:  Eur Spine J       Date:  2017-11-18       Impact factor: 3.134

6.  Clinical evaluation of an antiinflammatory and antioxidant diet effect in 30 dogs affected by chronic otitis externa: preliminary results.

Authors:  Alessandro Di Cerbo; Sara Centenaro; Francesca Beribè; Fulvio Laus; Matteo Cerquetella; Andrea Spaterna; Gianandrea Guidetti; Sergio Canello; Giuseppe Terrazzano
Journal:  Vet Res Commun       Date:  2016-01-07       Impact factor: 2.459

7.  Efficacy and safety of fluocinolone acetonide 0.025% otic solution in patients with otic eczema: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Victoria Montoro; Carlos Asensio; Ángel Martínez; Juan Lorente; Francisco J Rodríguez; José Montojo; Javier Gavilanes; Pedro Sarría; Cristóbal Langdon; Eduard Prades
Journal:  J Int Med Res       Date:  2018-08-24       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.